Indivisible Partners Takes Position in UnitedHealth Group Incorporated $UNH

Key Points

• Indivisible Partners opened a new position in UnitedHealth during Q4, acquiring 3,391 shares valued at about $1.12 million.
• UnitedHealth beat Q1 expectations with $7.23 EPS (vs. $6.76 est.) and $111.65 billion in revenue, and set FY‑2026 guidance at 18.25 EPS (sell‑side consensus ~18.29).
• Analyst sentiment is broadly positive—MarketBeat shows an average rating of "Moderate Buy" with a $378.88 average target, while firms including Barclays, Morgan Stanley and Jefferies raised targets and Goldman added UNH to its Conviction List with a $435 target.

Indivisible Partners acquired a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 3,391 shares of the healthcare conglomerate's stock, valued at approximately $1,119,000.

A number of other institutional investors and hedge funds also recently modified their holdings of UNH. Brighton Jones LLC increased its stake in shares of UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock valued at $22,384,000 after acquiring an additional 28,231 shares during the last quarter. Revolve Wealth Partners LLC increased its stake in shares of UnitedHealth Group by 137.1% during the 4th quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock valued at $2,033,000 after acquiring an additional 2,324 shares during the last quarter. CMT Capital Markets Trading GmbH acquired a new position in shares of UnitedHealth Group during the 2nd quarter valued at about $340,000. Flow Traders U.S. LLC purchased a new stake in shares of UnitedHealth Group during the 2nd quarter worth about $356,000. Finally, Jump Financial LLC purchased a new stake in shares of UnitedHealth Group during the 2nd quarter worth about $377,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on UNH shares. Barclays boosted their target price on UnitedHealth Group from $327.00 to $373.00 and gave the stock an "overweight" rating in a report on Wednesday, April 22nd. KeyCorp reiterated an "overweight" rating on shares of UnitedHealth Group in a report on Wednesday, January 28th. UBS Group decreased their target price on UnitedHealth Group from $430.00 to $410.00 and set a "buy" rating for the company in a report on Wednesday, January 28th. Morgan Stanley upped their price target on UnitedHealth Group from $375.00 to $395.00 and gave the stock an "overweight" rating in a report on Wednesday, April 22nd. Finally, Jefferies Financial Group upped their price target on UnitedHealth Group from $340.00 to $373.00 and gave the stock a "buy" rating in a report on Monday, April 20th. One equities research analyst has rated the stock with a Strong Buy rating, twenty have given a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $378.88.

UnitedHealth Group Stock Up 0.9%

NYSE UNH opened at $367.11 on Thursday. The stock has a market cap of $333.41 billion, a PE ratio of 27.73, a P/E/G ratio of 1.57 and a beta of 0.64. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $395.52. The business has a 50 day moving average price of $302.62 and a two-hundred day moving average price of $316.89. The company has a quick ratio of 0.79, a current ratio of 0.80 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, April 21st. The healthcare conglomerate reported $7.23 EPS for the quarter, beating the consensus estimate of $6.76 by $0.47. The company had revenue of $111.65 billion during the quarter, compared to analysts' expectations of $109.84 billion. UnitedHealth Group had a return on equity of 14.65% and a net margin of 2.68%.The business's revenue was up 2.0% on a year-over-year basis. During the same period in the prior year, the business posted $7.20 EPS. UnitedHealth Group has set its FY 2026 guidance at 18.250- EPS. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 18.29 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 17th. Stockholders of record on Monday, March 9th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.4%. The ex-dividend date was Monday, March 9th. UnitedHealth Group's dividend payout ratio is 66.77%.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealthcare will eliminate prior-authorization requirements for roughly 30% of services, a move that can reduce administrative friction, improve member/provider experience and potentially cut costs over time — a clear operational positive for UNH. UnitedHealthcare removes prior approval requirements for 30% of healthcare services
• Positive Sentiment: Goldman Sachs added UNH to its U.S. Conviction List and maintained a $435 price target, signaling confidence from a major institutional desk that the company may be nearing the bottom of its underwriting cycle. Goldman Sachs Names UnitedHealth (UNH) to Conviction List, Keeps $435 Price Target
• Positive Sentiment: Investors are still digesting UNH’s strong Q1 results and the company’s raised 2026 guidance — earnings momentum and an improved profit footing remain central bullish drivers. How Investors Are Reacting To UnitedHealth Group (UNH) Earnings Beat, Guidance Hike and Governance Challenge
• Positive Sentiment: Analyst model revisions and shareholder-friendly actions support the case for upside: Zacks raised several near-term estimates (including FY‑2026) and analysts/narratives note increased buybacks as management signaling shares are attractive. According to These Metrics, UnitedHealth Stock Looks Undervalued
• Neutral Sentiment: Positive results from other healthcare companies (Tenet, CVS) underline industrywide improvement in utilization and pricing dynamics — a supportive backdrop for insurers like UNH but indirect in impact. THC Beats Q1 Earnings Estimates on Strong Ambulatory Growth, Ups '26 EPS View CVS Stock Breaks Out On Earnings Due To ACA Exit, Premium Hikes
• Negative Sentiment: Major outlets caution that Q1 medical-cost data are incomplete due to claims lag; Q2 will be the true test for underwriting recovery — if costs re-accelerate, margin pressure could re-emerge. Major health insurers show signs of recovery – but a key test looms
• Neutral Sentiment: Governance issues (a shareholder proposal to require an independent board chair) are being debated and could influence investor focus on oversight, but the near-term financial impact is unclear. How Investors Are Reacting To UnitedHealth Group (UNH) Earnings Beat, Guidance Hike and Governance Challenge

Insider Activity at UnitedHealth Group

In other news, CEO Patrick Hugh Conway sold 800 shares of the stock in a transaction that occurred on Thursday, April 23rd. The stock was sold at an average price of $355.00, for a total transaction of $284,000.00. Following the completion of the transaction, the chief executive officer directly owned 17,805 shares in the company, valued at approximately $6,320,775. This represents a 4.30% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Company insiders own 0.28% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.